NCT00501462View on ClinicalTrials.gov

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2Renal Insufficiency
Interventions
DRUG

GSK189075

single 250 mg dose of drug

Trial Locations (4)

32809

GSK Investigational Site, Orlando

37920

GSK Investigational Site, Knoxville

55404

GSK Investigational Site, Minneapolis

78752

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY